首页> 外文期刊>JMIR mHealth and uHealth >Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study
【24h】

Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study

机译:基于mHealth解决方案的耐治疗型精神分裂症(m-RESIST)患者的整体干预模型的用户接受度评估:一项定性研究

获取原文
获取外文期刊封面目录资料

摘要

Background Despite the theoretical potential of mHealth solutions in the treatment of patients with schizophrenia, there remains a lack of technological tools in clinical practice. Objective The aim of this study was to measure the receptivity of patients, informal carers, and clinicians to a European integral intervention model focused on patients with persistent positive symptoms: Mobile Therapeutic Attention for Patients with Treatment-Resistant Schizophrenia (m-RESIST). Methods Before defining the system requirements, a qualitative study of the needs of outpatients with treatment-resistant schizophrenia was carried out in Spain, Israel, and Hungary. We analyzed the opinions of patients, informal carers, and clinicians concerning the services originally intended to be part of the solution. A total of 9 focus groups (72 people) and 35 individual interviews were carried out in the 3 countries, using discourse analysis as the framework. Results A webpage and an online forum were perceived as suitable to get both reliable information on the disease and support. Data transmission by a smart watch (monitoring), Web-based visits, and instant messages (clinical treatment) were valued as ways to improve contact with clinicians. Alerts were appreciated as reminders of daily tasks and appointments. Avoiding stressful situations for outpatients, promoting an active role in the management of the disease, and maintaining human contact with clinicians were the main suggestions provided for improving the effectiveness of the solution. Conclusions Positive receptivity toward m-RESIST services is related to its usefulness in meeting user needs, its capacity to empower them, and the possibility of maintaining human contact.
机译:背景技术尽管mHealth解决方案在治疗精神分裂症患者方面具有理论潜力,但在临床实践中仍然缺乏技术工具。目的这项研究的目的是测量患者,非正式护理人员和临床医生对以持续阳性症状患者为重点的欧洲整体干预模型的接受度:针对难治性精神分裂症患者的移动治疗注意力(m-RESIST)。方法在定义系统要求之前,在西班牙,以色列和匈牙利进行了对具有抗药性的精神分裂症门诊患者需求的定性研究。我们分析了患者,非正式护理人员和临床医生对最初打算作为解决方案一部分的服务的意见。以话语分析为框架,在这三个国家共进行了9个焦点小组(72人)和35次个人访谈。结果人们认为,一个网页和一个在线论坛既可以获取有关该疾病的可靠信息,也可以提供支持。智能手表的数据传输(监视),基于Web的访问和即时消息(临床治疗)被视为改善与临床医生联系的方式。警报被视为对日常任务和约会的提醒。为提高解决方案的有效性提供了主要建议,避免为门诊患者带来压力,在疾病管理中发挥积极作用,以及与临床医生保持人与人之间的联系。结论对m-RESIST服务的积极接受性与其在满足用户需求方面的有用性,赋予用户授权的能力以及与人类保持联系的可能性有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号